Nara, Japan

Keiko Yugawa

USPTO Granted Patents = 17 

Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 593(Granted Patents)


Location History:

  • Osaka, JP (1995 - 1996)
  • Kadoma, JP (2001)
  • Nara, JP (2002 - 2023)

Company Filing History:


Years Active: 1995-2023

Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Keiko Yugawa: A Pioneer in Infection Risk Evaluation

Introduction: Keiko Yugawa, an accomplished inventor based in Nara, Japan, has made significant strides in the field of healthcare innovation. With an impressive portfolio of 17 patents, she focuses on technologies that evaluate and manage infection risks, particularly within children's environments. Her work aims to enhance the understanding and prevention of infectious diseases in communities.

Latest Patents: Among Keiko’s most recent patents is a method for evaluating infection risk, which encompasses a systematic approach to calculating the likelihood of a child contracting an infectious disease. This method assesses various factors, including infection information from family members and prevalence rates of diseases in associated organizations. The process involves calculating a first infection risk value and a second infection risk value, which together provide a comprehensive evaluation of a child's risk in both familial and group settings.

Another noteworthy patent is related to an antibody capable of binding to norovirus. This innovation includes a specific structural domain designed to enhance the detection of this virus, showcasing Keiko's commitment to advancing diagnostic tools in healthcare.

Career Highlights: Keiko Yugawa's career includes notable tenures at Matsushita Electric Industrial Co., Ltd. and Panasonic Intellectual Property Management Co., Ltd. Through her roles, she has contributed to meaningful inventions that bridge technological advancements with public health needs.

Collaborations: In her professional journey, Keiko has collaborated with esteemed colleagues such as Shiro Nankai and Hiroshi Nakayama. These partnerships have fostered an environment of innovation, allowing for the development of impactful solutions to pressing health issues.

Conclusion: Keiko Yugawa stands out as a significant figure in the realm of healthcare innovation, particularly in the evaluation of infection risks among children. Her patented inventions demonstrate her dedication to improving public health outcomes and her ability to leverage technology for social good. With each new patent, Keiko continues to pave the way for advancements in the understanding and management of infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…